ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1699

Training Residents to ‘Choose Wisely’ When Testing for Antinuclear Antibodies

Iman Qaiser1, Tracy Koehler1 and Richard Martin2, 1Mercy Health Saint Mary's, Grand Rapids, MI, 2Michigan State University College of Human Medicine, Grand Rapids, MI

Meeting: ACR Convergence 2020

Keywords: Clinical practice guidelines, Decision analysis, education, medical, Qualitative Research, Surveys

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: Professional Education Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: In many hospitals residents are the first providers to evaluate new patients. Consequently, residents often initiate the work-up of newly admitted patients. Multiple studies have shown that anti-nuclear antibody (ANA) testing is overutilized in both inpatient and outpatient settings 1,2. Inappropriate ordering and misinterpretation of this test can lead to a subsequent cascade of unnecessary investigation which may lead to iatrogenic harm and waste resources. ABIM/ACR “Choosing Wisely” recommendations include:  Don’t test ANA sub-serologies without a positive ANA and clinical suspicion of immune-mediated disease. 

Thus, it is vital that residents receive training about appropriate ANA testing. The aim of this study was to assess the effectiveness of an educational intervention on the appropriateness of ordering ANA testing in a community-based internal medicine program.

Methods: A 30-minute evidence-based presentation on ANA testing was developed and delivered to residents, medical students and faculty attending the weekly Internal Medicine (IM) resident didactics. Topics covered included:

  1. ACR’s “Choosing Wisely” recommendations for ANA testing
  2. Clinical scenarios with discussions of appropriateness of ordering ANA in different patient cases
  3. Methods used for ANA testing
  4. Operating characteristics of ANA including: sensitivity, specificity and positive predictive value.
  5. Interpretation of titers, patterns and specific ANA antibodies.

Five patient case scenarios evaluating each of the covered knowledge domains were created for use as a pre/post-test measure. These were administered as a pre and post-intervention test to all attendees. To assure the content validity of the presentation, the presentation and questionnaire were reviewed, edited and approved by the IM Residency Education Director (a hospitalist), an IM residency core faculty (a primary care physician), a Scholarly Activity support person and a board-certified rheumatologist. To assess the quality of test questions we conducted item analysis 3.

Results: Thirteen residents, three medical students and one faculty member participated. The median percentage of correct answers for the pre and post-tests were  40% and 60%, respectively (Figure 1). The number of correct answers increased in 4 of 5 questions and decreased in the 5th question. The mean item difficulty index was 0.529 (range 0.235 – 0.941) and mean discrimination index was 0.305 (range 0.235-.353). All were above the 0.20 threshold which is considered satisfactory.

Conclusion: Residents should be educated regarding the ACR Choosing Wisely recommendations. The intervention overall showed improved knowledge scores on post-tests.  Revision of test questions may provide better discrimination of knowledge gains.

References

  1. Davis LA, Goldstein B, Tran V, Keniston A, et al. Applying choosing wisely: antinuclear antibody (ANA) and sub-serology testing in a safety net hospital system. Open Rheumatol J. 2015;9:82‐87.
  2. Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med. 2013;126:342-8.
  3. Mehrens WA, Lehmann IJ. Measurement in Education and Psychology. Fort Worth (TX): Harcourt Brace College Publishers; 1991.p160-166

Figure 1. Median Percent Correct and Percent Correct by Questions


Disclosure: I. Qaiser, None; T. Koehler, None; R. Martin, Abbvie, 9, Amgen, 9, Eli Lilly, 9.

To cite this abstract in AMA style:

Qaiser I, Koehler T, Martin R. Training Residents to ‘Choose Wisely’ When Testing for Antinuclear Antibodies [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/training-residents-to-choose-wisely-when-testing-for-antinuclear-antibodies/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/training-residents-to-choose-wisely-when-testing-for-antinuclear-antibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology